Literature DB >> 6603463

Computed tomography and positron emission transaxial tomography evaluations of normal aging and Alzheimer's disease.

M J de Leon, S H Ferris, A E George, B Reisberg, D R Christman, I I Kricheff, A P Wolf.   

Abstract

Young normal subjects, old normal subjects, and patients with senile dementia of the Alzheimer's type (SDAT) were studied with both computed tomography (CT) and positron emission transaxial tomography (PETT). Increases in ventricular size with both aging and disease were measured. Regional glucose metabolic rate was not affected by age, but was markedly reduced in SDAT patients. These data indicate that in normal aging, structural brain changes may be more salient than biochemical changes. Although both structural and biochemical changes occur in SDAT, the biochemical changes are more marked. The results suggest that PETT is potentially more useful than CT in the in vivo diagnosis of SDAT.

Entities:  

Mesh:

Year:  1983        PMID: 6603463     DOI: 10.1038/jcbfm.1983.57

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  36 in total

Review 1.  The concept of FDG-PET endophenotype in Alzheimer's disease.

Authors:  Emmanuel H During; R S Osorio; F M Elahi; L Mosconi; M J de Leon
Journal:  Neurol Sci       Date:  2011-06-01       Impact factor: 3.307

2.  Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults.

Authors:  Gene E Alexander; Kaitlin L Bergfield; Kewei Chen; Eric M Reiman; Krista D Hanson; Lan Lin; Daniel Bandy; Richard J Caselli; James R Moeller
Journal:  Neurobiol Aging       Date:  2012-03-08       Impact factor: 4.673

3.  Understanding dementia prevalence among centenarians.

Authors:  Leonard W Poon; John L Woodard; L Stephen Miller; Robert Green; Marla Gearing; Adam Davey; Jonathan Arnold; Peter Martin; Ilene C Siegler; Lusine Nahapetyan; Young Sek Kim; William Markesbery
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-01       Impact factor: 6.053

4.  Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice.

Authors:  Yanxing Chen; Zhihou Liang; Zhu Tian; Julie Blanchard; Chun-Ling Dai; Sonia Chalbot; Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Mol Neurobiol       Date:  2013-08-31       Impact factor: 5.590

5.  Twelve-month metabolic declines in probable Alzheimer's disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Kewei Chen; Jessica B S Langbaum; Adam S Fleisher; Napatkamon Ayutyanont; Cole Reschke; Wendy Lee; Xiaofen Liu; Dan Bandy; Gene E Alexander; Paul M Thompson; Norman L Foster; Danielle J Harvey; Mony J de Leon; Robert A Koeppe; William J Jagust; Michael W Weiner; Eric M Reiman
Journal:  Neuroimage       Date:  2010-03-02       Impact factor: 6.556

6.  Moderate Physical Activity is Associated with Cerebral Glucose Metabolism in Adults at Risk for Alzheimer's Disease.

Authors:  Ryan J Dougherty; Stephanie A Schultz; Taylor K Kirby; Elizabeth A Boots; Jennifer M Oh; Dorothy Edwards; Catherine L Gallagher; Cynthia M Carlsson; Barbara B Bendlin; Sanjay Asthana; Mark A Sager; Bruce P Hermann; Bradley T Christian; Sterling C Johnson; Dane B Cook; Ozioma C Okonkwo
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 7.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

Review 8.  Brain metabolism in health, aging, and neurodegeneration.

Authors:  Simonetta Camandola; Mark P Mattson
Journal:  EMBO J       Date:  2017-04-24       Impact factor: 11.598

9.  PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.

Authors:  Weiping Qin; Vahram Haroutunian; Pavel Katsel; Christopher P Cardozo; Lap Ho; Joseph D Buxbaum; Giulio M Pasinetti
Journal:  Arch Neurol       Date:  2009-03

10.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.